Biohaven Pharmaceutical Holding Co Ltd (BHVN) stock is higher by 43.80% over the last 12 months, and the average rating from Wall Street analysts is a Strong Buy. InvestorsObserver’s proprietary ranking system, gives BHVN stock a score of 70 out of a possible 100.
That rank is influenced by a short-term technical score of 90. BHVN's rank also includes a long-term technical score of 80. The fundamental score for BHVN is 40. In addition to the average rating from Wall Street analysts, BHVN stock has a mean target price of 86. This means analysts expect the stock to gain 36.51% over the next 12 months.
What's Happening with BHVN Stock Today
Biohaven Pharmaceutical Holding Co Ltd (BHVN) stock has fallen -0.51% while the S&P 500 is higher by 0.98% as of 1:21 PM on Thursday, Sep 24. BHVN is down -$0.32 from the previous closing price of $63.32 on volume of 573,944 shares. Over the past year the S&P 500 is up 9.51% while BHVN is higher by 43.80%. BHVN lost -$11.04 per share in the over the last 12 months.
